Professional Reference articles are designed for health professionals to use. They are written by UK doctors and based on research evidence, UK and European Guidelines. You may find one of our health articles more useful.
Synonym: Harrison and Smyth's syndrome, subclavian steal syndrome, SSS
The subclavian steal phenomenon (SSP) occurs when there is stenosis or occlusion of the subclavian artery proximal to the vertebral artery origin, causing reversed flow in the ipsilateral vertebral artery. Blood is 'stolen' from the circular vertebrobasilar system to supply the distal territory of the occluded or stenosed artery. Retrograde flow in the vertebral artery, associated with a subclavian or innominate (brachiocephalic) artery stenosis, can be an incidental finding during Doppler ultrasound examination of the cerebral supply.
Subclavian stenoses are most often asymptomatic and therefore do not need any treatment. The term 'subclavian steal syndrome' should only be used in cases where this aberrant blood flow causes symptoms which affect the brain, upper limb or the heart. These are related to reduced cerebral perfusion when the arm ipsilateral to the subclavian stenosis is exercised.
Anatomy and blood flow in subclavian steal phenomenon
SSP affects the left side much more commonly than the right, with relative incidence about 3-4:1.
NB: if the left vertebral artery arises directly from the aortic arch (as it does in 2% of the population), stenosis of the proximal left subclavian artery cannot cause the syndrome because there is no communication between the vertebral and subclavian arteries.
This is a relatively uncommon disorder. Its incidence has been reported as between 0.1% and 3.4% of adults.
SSP is seen as an incidental finding on sonography of the vertebral system in about 2-5% of those examined. Of these, only about 5% of these patients suffer symptoms.
As the majority of cases are due to atherosclerosis, risk factors for SSP are as for cardiovascular disease (CVD) in general:
- Family history of vascular disease.
Thoracic outlet syndrome and stenosis after surgical repair of aortic coarctation or Fallot's tetralogy (with a Blalock-Taussig shunt) are other possible causes.
In Asia, a significant proportion of SSP (36%) is caused by Takayasu's arteritis. These tend to present at a much earlier age (<30 years) and have a female predominance. Takayasu's arteritis is a very rare disease in Europe.
Only a minority of patients with subclavian steel stenosis have symptoms. Arm claudication is the most common complaint; pain or fatigue in the arm occurs following exercise.
Seek a history of a provoking event that is clearly linked to symptoms. These may be reproducible. Symptoms are usually related to vertebrobasilar and posterior cerebral circulation ischaemia.
On exercising the upper limb on the affected side, the patient may experience any of the following:
- Visual loss, ranging from unilateral visual field loss (amaurosis fugax) to bilateral total blindness.
- Transient periods of ataxia, diplopia, dysphagia and dysarthria.
- Tingling or numbness of the face, sensory hemianaesthesia affecting the body or transient hemiparesis.
- Intermittent arm claudication. (NB: rest pain is not a usual feature; consider atheroembolism as a cause.)
- Coolness or paraesthesia of the arm may occur either at rest of with exertion.
- Drop attacks (syncope) - fall to the ground without warning, ± temporary loss of consciousness with immediate recovery.
- Dizziness, diplopia, nystagmus, tinnitus or even hearing loss may occur.
- Blood pressure is decreased (>15 mm Hg) in the affected arm distal to the steno-occlusive disease.
- However, even a difference in systolic blood pressure of 10 mm Hg or more between arms has been shown to be strongly associated with subclavian stenosis.
- Check radial and ulnar pulses and elevate the arm, where they may be felt to diminish. It is unusual for a case of genuine subclavian steal syndrome to have no difference in blood pressure between the two arms.
- A subclavian bruit may be audible.
- Aortic dissection.
- Giant cell arteritis (temporal arteritis).
- Takayasu's arteritis.
- Cerebral/cerebellar pathology - eg, multiple sclerosis, brain tumour.
- Doppler ultrasound or angiography shows retrograde flow down the vertebral artery (often an asymptomatic, incidental finding).
- Scanning with duplex ultrasonography and transcranial Doppler is more sensitive than conventional angiography for detecting flow reversal.
- Magnetic resonance angiography offers comparable resolution to computed tomography angiography but is more expensive and less widely available.
- CT or MRI scanning may be undertaken to exclude intracerebral lesion and show any infarcts.
Other investigations may include:
- Colour Doppler ultrasound.
- CXR - to exclude external compression by, for example, cervical rib.
Even asymptomatic subclavian artery stenosis is associated with increased risk of cardiovascular disease.Therefore, medical treatment that includes beta-blockers, angiotensin-converting enzyme (ACE) inhibition, and a statin is usually recommended.
Percutaneous transluminal angioplasty (+/- stenting) or surgery (carotid-subclavian bypass with either synthetic graft or saphenous vein graft or carotid-subclavian transposition) can both be used to bypass the stenosis of the subclavian artery. Technical success of the percutaneous approach can be achieved in over 90% of cases, with five-year patency rates of 85%.Longer or more distal occlusions are usually managed by surgery.
Endovascular methods are increasingly popular, particularly in high-risk patients, due to their minimally invasive approach under local anaesthetic.
Where symptoms are not severe, conservative management is usually recommended.
Symptoms may spontaneously resolve due to the establishment of extracranial collaterals to the subclavian circulation.
Treatment is therefore usually reserved for patients with debilitating vertebrobasilar transient ischaemic attacks. The outcome for patients who have antegrade vertebral blood flow re-established, either by surgical revascularisation or endovascular stenting of the diseased subclavian artery, is now excellent.
More generally, subclavian stenosis is significantly associated with increased total and CVD-related death, independent of other cardiovascular risk factors.
Associated steal syndromes
Coronary-subclavian steal syndrome
Usually iatrogenic and follows coronary artery bypass grafting utilising the internal mammary artery.Subclavian stenosis causes 'stealing' of coronary blood flow via the arterial anastomosis, causing angina.
Spinal artery steal syndrome
This very rare condition occurs due to vertebral artery flow reversal, to supply blood to the spinal cord, caused by proximal vertebral artery occlusion..
Further reading and references
; Coronary Subclavian Steal Syndrome. Am J Med. 2014 Mar 20. pii: S0002-9343(14)00233-2. doi: 10.1016/j.amjmed.2014.03.006.
; Subclavian steal syndrome. Circulation. 2014 Jun 3129(22):2320-3. doi: 10.1161/CIRCULATIONAHA.113.006653.
; Association of a difference in systolic blood pressure between arms with vascular disease and mortality: a systematic review and meta-analysis. Lancet. 2012 Mar 10379(9819):905-14. doi: 10.1016/S0140-6736(11)61710-8. Epub 2012 Jan 30.
; The epidemiology of subclavian stenosis and its association with markers of subclinical atherosclerosis: the Multi-Ethnic Study of Atherosclerosis (MESA). Atherosclerosis. 2010 Jul211(1):266-70. doi: 10.1016/j.atherosclerosis.2010.01.013. Epub 2010 Jan 21.
; Long-term results of endovascular therapy for proximal subclavian arterial obstructive lesions. Chin Med J (Engl). 2010 Jan 5123(1):45-50.
; Endovascular stenting for atherosclerotic subclavian artery stenosis in patients with other craniocervical artery stenosis. J Thromb Thrombolysis. 2013 Jan35(1):107-14. doi: 10.1007/s11239-012-0789-4.
; Coronary-subclavian steal syndrome: percutaneous approach. Case Rep Cardiol. 20132013:757423. doi: 10.1155/2013/757423. Epub 2013 Jul 29.
; Anterior spinal artery syndrome presenting as cervical myelopathy in a patient with subclavian steal syndrome. Neurol Clin Pract. 2013 Aug3(4):358-360.